Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease

Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease

Evaluation of the Long Term Safety, Tolerability and Efficacy of Two Dosing Regimens of Olokizumab (OKZ), in Subjects With Rheumatoid Arthritis (RA) Who Previously Completed 24 Weeks of Blinded Treatment in One of the Core Studies - CREDO 1, 2 or 3.

A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis

An Investigational Study to Evaluate BMS-986165 in Patients With Systemic Lupus Erythematosus

Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout

Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care

Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)